Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates.

Science Translational Medicine
Olivier HumbertHans-Peter Kiem

Abstract

Reactivation of fetal hemoglobin (HbF) is being pursued as a treatment strategy for hemoglobinopathies. Here, we evaluated the therapeutic potential of hematopoietic stem and progenitor cells (HSPCs) edited with the CRISPR-Cas9 nuclease platform to recapitulate naturally occurring mutations identified in individuals who express increased amounts of HbF, a condition known as hereditary persistence of HbF. CRISPR-Cas9 treatment and transplantation of HSPCs purified on the basis of surface expression of the CD34 receptor in a nonhuman primate (NHP) autologous transplantation model resulted in up to 30% engraftment of gene-edited cells for >1 year. Edited cells effectively and stably reactivated HbF, as evidenced by up to 18% HbF-expressing erythrocytes in peripheral blood. Similar results were obtained by editing highly enriched stem cells, defined by the markers CD34+CD90+CD45RA-, allowing for a 10-fold reduction in the number of transplanted target cells, thus considerably reducing the need for editing reagents. The frequency of engrafted, gene-edited cells persisting in vivo using this approach may be sufficient to ameliorate the phenotype for a number of genetic diseases.

References

Jan 14, 1988·The New England Journal of Medicine·C T NoguchiA N Schechter
Jun 9, 1994·The New England Journal of Medicine·O S PlattP P Klug
Jul 21, 1998·Annals of the New York Academy of Sciences·B G Forget
Jun 28, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·R S NegrinJ Klein
Jan 15, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·M C WaltersUNKNOWN Multicenter Investigation of Bone Marrow Transplantation for Sickle Cell Disease
Jan 15, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J M VoseJ O Armitage
Jul 25, 2006·Blood·Robert S FrancoDonald L Rucknagel
Jun 24, 2008·Bulletin of the World Health Organization·Bernadette Modell, Matthew Darlison
Nov 30, 2011·The Journal of Cell Biology·Eric M PietrasEmmanuelle Passegué
Apr 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Lan N TruongXiaohua Wu
Nov 14, 2013·Blood·Martin H SteinbergAbdulrahman Alsultan
Oct 11, 2014·Nucleic Acids Research·Eva K BrinkmanBas van Steensel
Dec 3, 2014·Molecular Therapy. Nucleic Acids·Thomas J CradickGang Bao
Dec 17, 2014·Nature Biotechnology·Shengdar Q TsaiJ Keith Joung
Sep 1, 2015·Nature Methods·Jeff VierstraJohn A Stamatoyannopoulos
Sep 17, 2015·Nature·Matthew C CanverDaniel E Bauer
Jan 20, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ciaran M LeeGang Bao
Apr 26, 2016·Molecular Therapy. Methods & Clinical Development·Otto-Wilhelm MertenChiara Bovolenta
Aug 9, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H B ZhengL S Kean
Sep 7, 2016·The Journal of Clinical Investigation·Christian BrendelDavid A Williams
Mar 2, 2017·The New England Journal of Medicine·Jean-Antoine RibeilMarina Cavazzana
Sep 9, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Allistair AbrahamUNKNOWN Center for International Blood and Marrow Transplant Research
Nov 3, 2017·Science Translational Medicine·Stefan RadtkeHans-Peter Kiem
Dec 26, 2017·Molecular Therapy. Methods & Clinical Development·Olivier HumbertHans-Peter Kiem
Jan 26, 2018·Nature Protocols·Rasmus O BakMatthew H Porteus
Apr 19, 2018·The New England Journal of Medicine·Alexis A ThompsonMarina Cavazzana
May 29, 2018·Experimental Hematology·Karine Sii-FeliceEmmanuel Payen
Jun 9, 2018·Expert Review of Hematology·Alexis Leonard, John F Tisdale
Jul 1, 2018·Seminars in Hematology·Erica B Esrick, Daniel E Bauer
Feb 2, 2019·Molecular Therapy. Methods & Clinical Development·Christopher T LuxDavid J Rawlings
Mar 27, 2019·Nature Medicine·Yuxuan WuDaniel E Bauer

❮ Previous
Next ❯

Citations

Nov 7, 2019·Scientific Reports·Tristan ScottKevin V Morris
May 15, 2020·Human Molecular Genetics·Selami DemirciJohn F Tisdale
Sep 9, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Karine Sii-FeliceEmmanuel Payen
Oct 19, 2019·Nature Biomedical Engineering·Daniel E Bauer
Sep 12, 2020·Scientific Reports·Hannah L WatryLuke M Judge
Jun 9, 2020·British Journal of Haematology·Olivier HumbertHans-Peter Kiem
Sep 9, 2020·The Journal of Clinical Investigation·Selami DemirciJohn F Tisdale
Jan 21, 2021·British Journal of Haematology·Betty S PaceAbdullah Kutlar
Feb 3, 2021·Journal of Clinical Medicine·Giacomo Frati, Annarita Miccio
Feb 13, 2021·Gene Therapy·Dimitrios Laurin WagnerMichael Schmueck-Henneresse
Oct 24, 2020·Genes & Genomics·Zhabiz Golkar
Jan 19, 2021·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·So Hyun Park, Gang Bao
Aug 18, 2020·Molecular Therapy. Methods & Clinical Development·Stefan RadtkeHans-Peter Kiem
Feb 23, 2021·Molecular Therapy. Methods & Clinical Development·Suvd ByambaaYutaka Hanazono
Mar 19, 2021·American Journal of Human Genetics·Xiuqin BaoXiangmin Xu
Mar 20, 2021·Molecular Therapy. Nucleic Acids·Mai H TranMichael Farzan
Apr 1, 2021·Stem Cell Reviews and Reports·Karthik V KaruppusamySaravanabhavan Thangavel
Apr 14, 2021·Nature Genetics·Mitchell L LeibowitzDavid Pellman
Apr 16, 2021·The Journal of Clinical Investigation·Phillip A DoerflerMitchell J Weiss
Jul 3, 2021·Cells·Lola KonialiMarina Kleanthous
May 16, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lei YangDali Li
Sep 13, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Byung-Chul LeeCynthia E Dunbar
Sep 13, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gregory A Newby, David R Liu
Oct 11, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tolulope O Rosanwo, Daniel E Bauer
Oct 4, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lucy H MaynardHans-Peter Kiem

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Related Papers

Mediterranean Journal of Hematology and Infectious Diseases
Marco Gabbianelli, Ugo Testa
© 2021 Meta ULC. All rights reserved